Wall Street Journal article highlights Armstrong's research
Dimethylamylamine, or DMAA, is a key ingredient in supplements used by weightlifters looking to amp up before working out and dieters trying to curb their appetites. But it has raised health concerns, The Wall Street Journal reported. The Defense Department pulled supplements containing DMAA from military base shelves last year on concerns it played a role in two soldiers' deaths. The Food and Drug Administration in April warned supplement makers and suppliers using DMAA that they hadn't shown that it is safe. DMAA use in supplements relies on a 1996 study in the now-defunct Journal of the Guizhou Institute of Technology, which said it found DMAA in a type of geranium. On that basis, supplement makers marketed the ingredient as naturally occurring. But on Thursday, a study in the peer-reviewed journal Drug Testing and Analysis led by UT Arlington chemist Daniel Armstrong described how tests detected no DMAA in eight geranium oil samples from different regions.
Robot technology could lead to early autism detection, treatment
Researchers from The University of Texas at Arlington and the University of North Texas Health Science Center are collaborating on a project aimed at earlier diagnosis for children with autism, the Fort Worth Star-Telegram reported. The research's hope is that it can lead to better treatment for children with autism. CBS 11, the NBC 5 4 p.m. and NBC 5 6 p.m. broadcasts also reported on the research.
12th Annual Autocross held at UT Arlington
WFAA and CW 33 reported on the 12th annual Texas Autocross competition held this weekend at The University of Texas at Arlington. Formula racers from many university engineering schools attended the event. The Fort Worth Star-Telegram featured an photo gallery on the event.